Trehu Elizabeth
Insider CIK 1693456 · CNST Director · JNCE Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| JNCE Jounce Therapeutics, Inc. | S Sale | 2023-01-10 | 2023-01-11 | 5,126 | $1.12 | $5.7K | 103,417 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2023-01-09 | 2023-01-11 | 4,159 | $1.10 | $4.6K | 108,543 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2022-02-01 | 2022-02-03 | 55,000 | — | $0 | 55,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award | 2022-02-01 | 2022-02-03 | 27,500 | — | $0 | 112,702 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2022-01-10 | 2022-01-11 | 5,378 | $6.65 | $35.8K | 85,202 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2022-01-07 | 2022-01-11 | 3,005 | $7.30 | $21.9K | 90,580 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | D To issuer deriv | 2021-07-15 | 2021-07-19 | 13,171 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | D To issuer deriv | 2021-07-15 | 2021-07-19 | 26,342 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | D To issuer deriv | 2021-07-15 | 2021-07-19 | 13,171 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | D To issuer deriv | 2021-07-15 | 2021-07-19 | 13,171 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | A Award deriv | 2021-06-02 | 2021-06-04 | 13,171 | — | $0 | 13,171 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise deriv | 2021-03-31 | 2021-03-31 | 8,300 | — | $0 | 203,885 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-03-31 | 2021-03-31 | 8,300 | $10.09 | $83.7K | 93,585 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise | 2021-03-31 | 2021-03-31 | 8,300 | $4.02 | $33.4K | 101,885 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise deriv | 2021-03-30 | 2021-03-31 | 100 | — | $0 | 212,185 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-03-30 | 2021-03-31 | 100 | $10.00 | $1.0K | 93,585 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise | 2021-03-30 | 2021-03-31 | 100 | $4.02 | $402 | 93,685 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise deriv | 2021-03-29 | 2021-03-31 | 5,100 | — | $0 | 212,285 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise | 2021-03-29 | 2021-03-31 | 5,100 | $4.02 | $20.5K | 98,685 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-03-29 | 2021-03-31 | 5,100 | $10.09 | $51.5K | 93,585 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2021-02-01 | 2021-02-03 | 44,500 | — | $0 | 44,500 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award | 2021-02-01 | 2021-02-03 | 22,250 | — | $0 | 93,585 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise deriv | 2021-01-20 | 2021-01-22 | 6,500 | — | $0 | 7,050 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-01-20 | 2021-01-22 | 6,500 | $12.01 | $78.1K | 71,335 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise | 2021-01-20 | 2021-01-22 | 6,500 | $4.02 | $26.1K | 77,835 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-01-08 | 2021-01-11 | 2,846 | $7.00 | $19.9K | 71,335 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-01-07 | 2021-01-11 | 2,452 | $6.76 | $16.6K | 74,181 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2020-08-17 | 2020-08-18 | 454 | $4.86 | $2.2K | 77,377 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2020-08-14 | 2020-08-18 | 744 | $4.71 | $3.5K | 76,633 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2020-08-14 | 2020-08-18 | 984 | $4.64 | $4.6K | 77,831 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | A Award deriv | 2020-06-04 | 2020-06-08 | 13,171 | — | $0 | 13,171 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2020-02-03 | 2020-02-04 | 44,500 | — | $0 | 44,500 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award | 2020-02-03 | 2020-02-04 | 22,250 | — | $0 | 78,815 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2020-01-07 | 2020-01-10 | 2,624 | $7.78 | $20.4K | 56,565 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2019-08-16 | 2019-08-16 | 1,018 | $3.92 | $4.0K | 59,189 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2019-08-15 | 2019-08-16 | 648 | $4.00 | $2.6K | 60,207 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2019-08-14 | 2019-08-16 | 670 | $4.10 | $2.7K | 60,855 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | A Award deriv | 2019-06-06 | 2019-06-10 | 13,171 | — | $0 | 13,171 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2019-02-01 | 2019-02-05 | 44,500 | — | $0 | 44,500 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award | 2019-02-01 | 2019-02-05 | 22,250 | — | $0 | 61,525 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | A Award deriv | 2018-09-04 | 2018-09-05 | 26,342 | — | $0 | 26,342 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award | 2018-08-13 | 2018-08-15 | 14,400 | — | $0 | 39,275 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise deriv | 2018-06-08 | 2018-06-12 | 24,875 | $4.02 | $100.0K | 217,385 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise | 2018-06-08 | 2018-06-12 | 24,875 | $4.02 | $100.0K | 24,875 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise deriv | 2018-03-08 | 2018-03-12 | 4,545 | — | $0 | 242,260 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2018-03-08 | 2018-03-12 | 4,545 | $25.06 | $113.9K | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise | 2018-03-08 | 2018-03-12 | 4,545 | $4.02 | $18.3K | 4,545 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise deriv | 2018-03-05 | 2018-03-07 | 4,545 | — | $0 | 246,805 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2018-03-05 | 2018-03-07 | 3,179 | $21.24 | $67.5K | 1,366 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2018-03-05 | 2018-03-07 | 1,366 | $22.11 | $30.2K | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise | 2018-03-05 | 2018-03-07 | 4,545 | $4.02 | $18.3K | 4,545 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2018-02-01 | 2018-02-05 | 70,500 | — | $0 | 70,500 | SEC↗ |